title: Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.
abstract: Oxidative stress and inflammation are important pathological mechanisms in many neurodegenerative diseases, including age-related macular degeneration (AMD). The very low-density lipoprotein receptor knockout mouse (Vldlr-/-) has been identified as a model for AMD and in particular for retinal angiomatous proliferation (RAP). In this study we examined the effect of cerium oxide nanoparticles (nanoceria) that have been shown to have catalytic antioxidant activity, on expression of 88 major cytokines in the retinas of Vldlr-/- mice using a PCR array. A single intravitreal injection of nanoceria at P28 caused inhibition of pro-inflammatory cytokines and pro-angiogenic growth factors including Tslp, Lif, Il3, Il7, Vegfa, Fgf1, Fgf2, Fgf7, Egf, Efna3, Lep, and up-regulation of several cytokines and anti-angiogenic genes in the Vldlr-/- retina within one week. We used the Ingenuity Pathway Analysis software to search for biological functions, pathways, and interrelationships between gene networks. Many of the genes whose activities were affected are involved in cell signaling, cellular development, growth and proliferation, and tissue development. Western blot analysis revealed that nanoceria inhibit the activation of ERK 1/2, JNK, p38 MAP kinase, and Akt. These data suggest that nanoceria may represent a novel therapeutic strategy to treat AMD, RAP, and other neurodegenerative diseases.
authors: Department of Ophthalmology/Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Electronic address: svkiosseva@uams.edu.
authors: Svetlana V
authors: SV
authors: Kyosseva
authors: Lijuan
authors: L
authors: Chen
authors: Sudipta
authors: S
authors: Seal
authors: James F
authors: JF
authors: McGinnis
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002563:Cerium / Q000008:administration & dosage*; D016207:Cytokines / Q000096:biosynthesis / Q000235:genetics*; D004195:Disease Models, Animal; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D058449:Intravitreal Injections; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D018384:Oxidative Stress; D012313:RNA / Q000235:genetics*; D060888:Real-Time Polymerase Chain Reaction; D011973:Receptors, LDL / Q000235:genetics / Q000378:metabolism; D012160:Retina / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D015861:Retinal Neovascularization / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D012173:Retinitis / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology
chemical_list: D016207:Cytokines; D011973:Receptors, LDL; C036053:VLDL receptor; D002563:Cerium; C030583:ceric oxide; D012313:RNA
keywords: PCR array; Vldlr mouse; age related macular degeneration; inflammation; nanoceria; oxidative stress
references: J Genet. 2009 Dec;88(4):495-515
references: 20090210
references: Retina. 2003 Aug;23(4):518-22
references: 12972764
references: Am J Pathol. 2008 Mar;172(3):638-49
references: 18276784
references: Invest Ophthalmol Vis Sci. 1994 Jul;35(8):3178-88
references: 7519180
references: Arch Ophthalmol. 2004 Apr;122(4):564-72
references: 15078675
references: Neurobiol Dis. 2011 Jun;42(3):514-23
references: 21396448
references: Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1275-81
references: 20185837
references: Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11875-80
references: 18711124
references: PLoS One. 2008 Jun 04;3(6):e2339
references: 18523633
references: Genes Dev. 2008 Feb 15;22(4):416-29
references: 18281458
references: Prog Retin Eye Res. 2009 Jan;28(1):1-18
references: 19026761
references: Retina. 2010 Oct;30(9):1350-67
references: 20924259
references: Ophthalmology. 2009 Feb;116(2):362
references: 19187826
references: Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3076-82
references: 20107175
references: Am J Pathol. 2000 Jul;157(1):135-44
references: 10880384
references: Acta Ophthalmol. 2011 Feb;89(1):82-90
references: 19764912
references: Circulation. 2003 Mar 18;107(10):1411-7
references: 12642363
references: Invest Ophthalmol Vis Sci. 2008 Jan;49(1):407-15
references: 18172119
references: J Neurosci Res. 2005 Feb 1;79(3):329-39
references: 15614790
references: JOM (1989). 2008 Mar 1;60(3):33-37
references: 20617106
references: Trends Immunol. 2004 Jun;25(6):280-8
references: 15145317
references: Free Radic Biol Med. 2011 Sep 15;51(6):1155-63
references: 21704154
references: Cardiovasc Res. 2007 Feb 1;73(3):549-59
references: 17207782
references: Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4614-23
references: 17003459
references: Exp Eye Res. 2009 Jan;88(1):79-91
references: 19013152
references: PLoS One. 2013;8(3):e58431
references: 23536794
references: Biomaterials. 2007 Apr;28(10):1918-25
references: 17222903
references: Invest Ophthalmol Vis Sci. 2010 Feb;51(2):991-1001
references: 19815726
references: Exp Eye Res. 2006 Apr;82(4):664-73
references: 16359662
references: Trends Cardiovasc Med. 2000 Jul;10(5):183-8
references: 11282292
references: Arch Ophthalmol. 2004 Apr;122(4):598-614
references: 15078679
references: Invest Ophthalmol Vis Sci. 2006 Jan;47(1):329-35
references: 16384981
references: Mediators Inflamm. 2010;2010:
references: 20871825
references: Chem Commun (Camb). 2007 Mar 14;(10):1056-8
references: 17325804
references: Ophthalmology. 2001 Apr;108(4):705-10
references: 11297487
references: Invest Ophthalmol Vis Sci. 2011 Apr 25;52(5):2809-16
references: 21282584
references: Cell Signal. 2011 Oct;23(10):1515-27
references: 21620960
references: J Exp Med. 2006 Feb 20;203(2):269-73
references: 16432252
references: Small. 2009 Dec;5(24):2848-56
references: 19802857
references: Vision Res. 2003 Apr;43(8):899-912
references: 12668059
references: Retina. 2001;21(5):416-34
references: 11642370
references: Nano Lett. 2005 Dec;5(12):2573-7
references: 16351218
references: Br J Ophthalmol. 2008 Apr;92(4):448-50
references: 18369057
references: Neurobiol Dis. 2009 Jun;34(3):535-44
references: 19344761
references: Nature. 2010 May 27;465(7297):483-6
references: 20445537
references: Oxid Med Cell Longev. 2013;2013:374963
references: 23401740
references: Nat Med. 2003 Jun;9(6):669-76
references: 12778165
references: Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1098-105
references: 19834031
references: Invest Ophthalmol Vis Sci. 2011 Aug 22;52(9):6572-9
references: 21757581
references: J Angiogenes Res. 2010 Oct 08;2:21
references: 20932321
references: Nat Nanotechnol. 2006 Nov;1(2):142-50
references: 18654167
references: Surv Ophthalmol. 2000 Sep-Oct;45(2):115-34
references: 11033038
references: Microvasc Res. 2009 Jun;78(1):119-27
references: 19281829
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Mol Biosyst. 2010 Oct;6(10):1813-20
references: 20697616
references: Ann Med. 2006;38(7):450-71
references: 17101537
references: Mol Vis. 2005 Mar 16;11:201-7
references: 15788998
references: Arch Ophthalmol. 2007 Jun;125(6):795-803
references: 17562991
references: Int Rev Neurobiol. 2004;59:201-20
references: 15006489
references: Semin Ophthalmol. 2011 May;26(3):192-7
references: 21609232
references: Exp Eye Res. 2007 Jan;84(1):135-42
references: 17097084
references: Invest Ophthalmol Vis Sci. 2008 Feb;49(2):693-8
references: 18235016
references: Clin Ophthalmol. 2009;3:167-74
references: 19668561
references: Chem Biol Interact. 2005 Jan 15;151(2):143-9
references: 15698585
references: Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8453-7
references: 7667310
references: J Biol Chem. 2007 Nov 23;282(47):34420-8
references: 17890782
references: Mol Vis. 1999 Nov 03;5:32
references: 10562656
references: Invest Ophthalmol Vis Sci. 2009 Feb;50(2):844-50
references: 18936153
references: Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1793-800
references: 17389513
references: PLoS One. 2011 Feb 22;6(2):e16733
references: 21364932
references: Nat Rev Immunol. 2010 Oct;10(10):683-7
references: 20847745
references: J Clin Invest. 2009 Mar;119(3):611-23
references: 19188685
references: Chem Soc Rev. 2010 Nov;39(11):4422-32
references: 20717560
references: Br J Ophthalmol. 2011 Dec;95(12):1631-7
references: 21546514